theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Depression   

Questions discussed in this category


What strategies have you found most effective for obtaining prior authorization for newer antipsychotics and antidepressants?
How do you determine which medications are most likely to require prior authorization? How do you streamline the prior authorization process and fit i...
1 Answer available

Have you completed any training to prepare for offering psilocybin treatment in the event that it eventually becomes FDA-approved for difficult-to-treat depression?
If yes, what kind of training did you pursue? How do you see psilocybin fitting into your practice (or not)? Are there particular skills you feel woul...
2 Answers available

When do you consider the use of zuranolone to treat postpartum depression?
1 Answer available

How do you talk to patients about psychedelic clinical trials for the treatment of major depressive disorder or PTSD?
When do you consider referring a patient to a clinical trial? How have patients responded to being offered trial participation? What has your experien...
1 Answer available

When do you refer patients with difficult-to-treat depression for ECT rather than other interventional psychiatric treatments, such as TMS or esketamine?
2 Answers available
2583025603251502542225159

Related Topics

  • Psychiatry
  • General Outpatient Psychiatry
  • Major Depressive Disorder
  • Ketamine
  • Women's Mental Health
  • Neuromodulation
  • Electroconvulsive Therapy
  • Transcranial magnetic stimulation
  • Trauma Spectrum Disorders
  • Pulmonology

Copyright © 2025 theMednet
All Rights Reserved.